Mariana C. Castells, MD, AAAAI 22: Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome.
We are delighted to speak with Prof. Mariana Castells (Brigham and Women’s Hospital, Boston, MA) about Indolent Systemic Mastocytosis and Monoclonal Mast Cell Activation Syndrome.
The abstract entitled ‘A Phase 2/3 Study of BLU-263 in Patients with Indolent Systemic Mastocytosis or Monoclonal Mast Cell Activation Syndrome’ (Abstract #665) was presented at The American Academy of Allergy, Asthma & Immunology (AAAAI), February 25-28, 2022
Questions:
- Could you tell us a little about indolent systemic mastocytosis and monoclonal mast cell activation syndrome, and the unmet needs in their management? (00:25)
Disclosures: Mariana Castells has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the virtual AAAAI 2022.